commercialisation of EpitaxOs
EpitaxOs bone regeneration material
use of EpitaxOs
autologous bone
Growing bone
formation of bone
exceptional bone inducing properties of EpitaxOs
Regulatory submission of EpitaxOs
innovative property of EpitaxOs
synthetic bone graft materials
true bone inducing material
situ bone tissue regeneration
growth factors
synthetic materials
commercial scale infrastructure
commercial scale production infrastructure
product launch
marketing channel
production launch
allograft
Development
dental market
market acceptance
CHARME project
spinal market
golden standard autograft
evidence-based data
new generation of orthopaedic materials
product superiority
unique position
relevant study data
limited quantity available
cell-based technologies
technological maturity level TRL6
pain
extra operative procedure
disadvantages
cost-effective XPAND Biotechnology BV
Europe
approval
patientâ€™s
strategy
patented surface nano-structure
stem cells
defect site
patients
adverse effects
plan
key markets
quality of life
Establishment
abundant quantities
endpoints
body
objectives